期刊文献+

门诊高血压患者用药情况调查分析 被引量:12

Analysis of drug use of out patients with hypertension
下载PDF
导出
摘要 目的探讨我院门诊高血压药物的应用现状和趋势。方法调查分析我院门诊就医的高血压患者治疗药物处方7 920张,分析抗高血压药物的使用情况及治疗方案,监测药物使用的合理性。结果我院门诊最常用的降压药有7类20个品种,其中钙拮抗剂(CCB)占35%、β-受体阻滞剂占21%、血管紧张素转化酶抑制剂(ACEI)占18%、血管紧张素Ⅱ受体拮抗剂(ARB)占13%、利尿剂占9%、复方制剂占3%和中药制剂占1%;单种药物治疗占46.2%,联用2种或2种以上药物治疗占53.8%。硝苯地平缓释片(14.27%)、贝那普利(11.7%)和美托洛尔(11.4%)在同类药物中使用率最高。结论我院门诊抗高血压药物应用种类及降压治疗方案基本符合中国高血压防治指南及个体化治疗方案,应用长效抗高血压药物制剂及合理的联合用药是当今高血压治疗的主流。 Objective To investigate the status and trends of our hospital′s hypertension drugs application.Methods 7 920 prescriptions of hypertension out patients were analyzed.Results The most commonly used antihypertensive drugs in our hospital were seven classes and 20 varieties,in which the calcium channel blocker(CCB)accounted for 35%,β-blockers 21%,angiotensin Ⅱ-converting enzyme inhibitors(ACEI)18%,angiotensin Ⅱ receptor blocker(ARB)13%,diuretics 9%,compound preparations3% and traditional Chinese medicines 1%;Single-drug therapy accounted for 46.2%,combined with two or more kinds of drugs53.8%.Extended Release Nifedipine Tablets(14.27%),benazepril(11.7%),and metoprolol(11.4%)had the highest utilization rate in the same drug class.Conclusion Our hospital antihypertensive drug application types and antihypertensive treatment programs were in line with Chinese Hypertension Prevention Guide.Individualized treatment programs,long-acting anti-hypertensive drugs and rational drug combination formulation are the developing trend in the treatment of hypertension.
作者 张淑霞
出处 《西北药学杂志》 CAS 2016年第5期537-539,共3页 Northwest Pharmaceutical Journal
关键词 抗高血压药物 处方分析 联合用药 antihypertensive prescription analysis combination medicine
  • 相关文献

参考文献5

二级参考文献24

  • 1韩静.我院门诊抗高血压药的使用分析[J].中国药师,2005,8(11):962-963. 被引量:8
  • 2李为民,刘巍.2004《中国高血压防治指南》解读[J].中国实用内科杂志:临床前沿版,2006,26(10):1650-1652. 被引量:7
  • 3中国高血压联盟.中国高卓压防治指南:修订版[M].北京:人民卫生出版社,2005:7-8.
  • 4赵连友,刘国仗.高血压病防治进展与实践[M].北京:科学出版社,2003:106-110.
  • 5JacksonJH. Sobol skiJ, Krienke R. et al. Blood pressure control and pharmacotherapy patterns in the United States before and af?ter the release of theJoint national committee on the prevention. detection. evaluation. and treatment of high blood pressure (JNC 7) guidelines[j].J Am Board Fam Med.2008,21(6) :512-52l.
  • 6Egan BM, Yumin Zhao, Axon RN. US Trends in prevalence. awareness. treatment. and control of hypertension, 1988 - 2008[J].JAMA.2010.303(20) :2043-2050.
  • 7Law Malcolm. MorrisJK.Jordan Rachel, et al. Headaches and the treatment of blood pressure results from a meta-analysis of 94 randomized placebo-controlled trials with 24 000 participants[J]. Circulation, 2005.112(15) : 2301-2306.
  • 8Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: mera-analysis of randomised trials[J]. BMJ ? 2008,336 (7653) : 1121-1123.
  • 9Law MR, MorrisJK. Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospec?tive epidemiological studies[J]. BMJ .2009.338: b1665.
  • 10Elliott HL. Meredith PA. Preferential benefits of nifedipine GlTS in systolic hypertension and in combination with RAS blockade: further analysis of the ?ACTION? database in patients with angina[j].J Hum Hypertens.2011.25(l) :63-70.

共引文献25

同被引文献123

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部